Valuation: Roopa Industries Limited

Market Cap 308M 3.23M 2.83M 2.61M 2.41M 4.57M 4.65M 31.16M 12.24M 152M 12.14M 11.87M 522M P/E 2024
30.6x
P/E 2025 19.8x
Enterprise Value 607M 6.37M 5.57M 5.14M 4.74M 9M 9.15M 61.36M 24.1M 299M 23.9M 23.38M 1.03B EV / Sales 2024
0.97x
EV / Sales 2025 0.58x
Free-Float
36.13%
Yield 2024 *
-
Yield 2025 -
1 day-2.59%
1 week-6.68%
Current month-8.26%
1 month+0.52%
3 months-6.51%
6 months-2.81%
Current year+5.93%
1 week 45.14
Extreme 45.14
49.99
1 month 45.11
Extreme 45.11
54.78
Current year 38.1
Extreme 38.1
63.4
1 year 38.1
Extreme 38.1
63.4
3 years 37.4
Extreme 37.4
114.9
5 years 12.9
Extreme 12.9
114.9
10 years 6.82
Extreme 6.82
114.9
Manager TitleAgeSince
Chief Executive Officer 72 1997-12-31
Director of Finance/CFO - 2020-06-30
Compliance Officer - 2022-05-31
Director TitleAgeSince
Chairman 72 1997-12-31
Director/Board Member 69 1997-03-16
Director/Board Member 70 2015-11-02
Change 5-day change 1-year change 3-year change Capi.($)
-2.59%-6.68%-20.13%+7.69% 3.85M
-2.33%-2.09%+49.88%+170.51% 1,060B
-0.82%-2.30%+63.79%+62.00% 619B
-0.73%-4.98%+28.91%+82.99% 438B
+0.33%-1.17%+31.07%+27.09% 333B
-0.02%-2.85%+29.15%+45.24% 282B
-3.89%-11.22%+22.81%+27.30% 267B
+0.66%-1.42%-26.59%-37.71% 218B
-0.06%-2.88%+23.07%+62.33% 196B
-3.72%-1.10%+18.41%+70.56% 161B
Average -1.32%-3.59%+22.04%+51.80% 357.39B
Weighted average by Cap. -1.31%-2.96%+36.75%+83.91%

Financials

2024 2025
Net sales 714M 7.48M 6.55M 6.04M 5.58M 10.58M 10.76M 72.15M 28.34M 352M 28.1M 27.49M 1.21B 1.21B 12.7M 11.11M 10.25M 9.47M 17.96M 18.27M 122M 48.09M 597M 47.7M 46.66M 2.05B
Net income 15.19M 159K 139K 129K 119K 225K 229K 1.54M 603K 7.48M 598K 585K 25.73M 20.35M 213K 187K 172K 159K 302K 307K 2.06M 808K 10.02M 801K 784K 34.46M
Net Debt 228M 2.39M 2.09M 1.93M 1.78M 3.38M 3.43M 23.01M 9.04M 112M 8.96M 8.77M 386M 299M 3.13M 2.74M 2.53M 2.33M 4.43M 4.51M 30.21M 11.86M 147M 11.77M 11.51M 506M
Logo Roopa Industries Limited
Roopa Industries Limited is an India-based active pharma ingredient (API) and pharmaceutical intermediates manufacturing company. The Company is focused on its core business Triphenyl Phosphine (TPP) and its allied products. Its products include N,N- Dicyclohexylcarbodiimide (DCC); TPP; 5-Cyano Phthalide, and bromine and its derivatives. TPP is a product used by the manufacturers of Cephalosporin group of Antibiotics, Statins and others. TTP are more used in areas like specialty resins/paints, fire retardants, Phosphonium salts, phase transfer catalysts, products relating to agriculture and others. Glucosamine is a sheet anchor product of the Company, which is a nutraceutical/nutritional supplement. It has capabilities to deliver bromine and bromine compounds of any quantity and specifications, such as Meta Bromo Anisole, Tetra Butyl Ammonium Bromide, 1-Bromo-3-Chloropropane, 1-Acetoxy Ethyl Bromide and others, which are used in chemical and pharmaceutical industry.
Employees
51
Date Price Change Volume
26-07-10 ₹46.65 -2.59% 1,225
26-07-09 ₹47.89 -2.76% 626
26-07-08 ₹49.25 -0.71% 3
26-07-07 ₹49.60 -0.78% 1
26-07-06 ₹49.99 0.00% 820
  1. Stock Market
  2. Stocks
  3. ROOPAIND6 Stock